MedPath

Registry HBOT in DFU

Recruiting
Conditions
Diabetic Foot Ulcers
Registration Number
NCT06693180
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Brief Summary

Overview of available data to assess the benefits of HBOT to DFU patients

Detailed Description

10 year retrospective registry to measure outcomes regarding major amputations, mortality, hospital admissions in patients with a diabetic foot ulcer with peripheral ischaemia. Two groups will be compared: complementary HBOT and a control group.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Diabetes mellitus
  • Meggitt-Wagner classification grade 2-4, existing > 4 weeks
  • Complete 1 year follow-up
Exclusion Criteria
  • Chronic Obstructive Pulmonary Disease (COPD) GOLD IV
  • Treatment with chemotherapy, immunosuppressive drugs or systemic corticosteroids within the last 3 months
  • Metastasized malignancy
  • Left ventricular ejection fraction (EF) <20% or external pacemaker
  • Recent thoracic or middle ear surgery
  • Severe epilepsy
  • Uncontrollable high fever
  • Pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Major amputation rate1 year

Major (above the ankle) amputation rate

Secondary Outcome Measures
NameTimeMethod
Mortality1 year

Mortality

Amputation-free survival rate1 year

Amputation-free survival rate: percentage of patients who are alive with their leg.

Complete wound healing1 year

Complete wound healing

Pain score1 year

Pain score (10-point Visual Analogue Scale; 0= no pain, 10 is intolerable pain)

Additional vascular interventions1 year

Additional vascular interventions

Trial Locations

Locations (1)

Amsterdam UMC

🇳🇱

Amsterdam, Noord-Holland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath